News that has occurred frequently in recent days has brought depression into the public eye again. The development of depression is a gradual process. In addition to relying on medication and psychotherapy, the patient's own emotional regulation is also a very important part. Pfizer recently launched a new app called Moodivator for the management of depression.

Susan Kornstein, a professor of psychiatry at the Virginia Commonwealth University School of Medicine and a consultant for the APP, said that the development of Moodivator is designed to allow users to control emotions by setting goals, planning paths, and identifying emotional patterns at any time. An efficient, replicable model to treat depression.

Gustavo Rodriguez, director of Pfizer's medical department, said that Moodivator is not tied to any of Pfizer's depression drugs. In short, it is not a tool for assisting drugs. Anyone can download it from Apple's APP Store, but This app is indeed an effective depression solution. Millions of people in the United States are currently suffering from depression. Moodivator is Pfizer's first app for this group of patients. This app can motivate patients to actively cope with depression and help them to be active in the treatment of depression. Instead of blindly relying on drugs or psychotherapy.

In addition to this app, Pfizer has launched Zoloft and Pristiq on the market, and other recent new drugs include Rexulti from Otsuka and Brintellix from Takeda. However, Pfizer's previous survey data shows that 70% of patients who are treated for mental illness hope to have an APP that can help them effectively monitor their emotional state in daily life. This is the original intention of Pfizer to develop this app.

In addition to helping patients, this Moodivator is also very valuable for Pfizer itself. Pfizer can collect data on the patient's emotional state through the APP, research, analyze and report on the user's experience and treatment results, so as to draw lessons for future drug development and emotional management. However, Pfizer said that this data collection is anonymous and will not allow patients' information to be obtained by third parties, so patients can not worry about their own information security.

Toilet Cleaner

Toilet Cleaner,Toilet Bowl Cleaner,Toilet Cleaning,Toilet Cleaning Powder

Wuxi Keni Daily Cosmetics Co.,Ltd , https://www.kenicosmetics.com